-
time starting salary is normally in the range £36,130 to £45,413 with potential progression once in post to £48,149 Grade: 7 Full Time, Fixed Term contract up to August 2028 Closing date: 25th August
-
potential progression once in post to £48,149 Grade: 7 Fixed term contract for up to 42 months: Full time, 37.5 hours per week for three years; then part time, 18.75 hours per week for 6 months. Closing date
-
Full time starting salary is normally in the range £36,130 to £45,413 with potential progression once in post to £48,149 Grade: 7 Full Time, Fixed Term contract up to September 2028 Closing date: 21st
-
starting salary is normally in the range £36,130 to £45,413 with potential progression once in post to £48,149 Grade: 7 Part Time (30 hours per week) Fixed Term contract up to July 2027 Closing date: 11th
-
Full time starting salary is normally in the range £36,130 to £45,413 with potential progression once in post to £48,149 Grade: 7 Full Time, Fixed Term contract up to September 2026 Closing date: 17th
-
potential progression once in post to £48,149 Grade: 7 Full Time, Fixed Term contract up to August 2026 Closing date: 12th August 2025 Our offer to you People are at the heart of what we are and do
-
(HPB). The medical oncology grouping sees close to 550 new cases of these cancers a year. There is a large active clinical trials programme that spans phase 1 to phase 3. These patients have a poor
-
potential progression once in post to £46,974 Grade: 7 Full Time, Fixed Term contract up to June 2027 Closing date: 31 August 2025 International travel may be required for this role Background To create and
-
emergencies PCOS SEVa – a national programme addressing variation in the quality of care for polycystic ovary syndrome (PCOS) Role Summary Work within specified research grants and contribute to writing bids
-
, Edgbaston, Birmingham UK Full time starting salary is normally in the range £36,130 to £45,413 with potential progression once in post to £48,149 Grade: 7 Full Time, Fixed Term contract up to October 2030